Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
10-day Sequential Therapy vs 7-day Tailored Therapy for H. Pylori Eradication
NCT02373280Recruiting
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Aug 2014
- Primary completion
- Apr 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of esomeprazole, amoxicillin, clarithromycin, moxifloxacin, bismuth subsalicylate and 2 more in Helicobacter pylori infection (4 arms), sponsored by Seoul National University Bundang Hospital. Primary endpoint: Percentage of participants with successful H. pylori eradication at 6 weeks. Started Aug 2014; status: recruiting.
02
Drugs
esomeprazoleamoxicillinclarithromycinmoxifloxacinbismuth subsalicylate
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT02373280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02373280.